ArticlePloS one2021

Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients.

Susan M Taghioff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.